246 related articles for article (PubMed ID: 14645506)
21. Involvement of Oct-1 in transcriptional regulation of beta-casein gene expression in mouse mammary gland.
Zhao FQ; Adachi K; Oka T
Biochim Biophys Acta; 2002 Aug; 1577(1):27-37. PubMed ID: 12151092
[TBL] [Abstract][Full Text] [Related]
22. Silencing mediator for retinoid and thyroid hormone receptors interacts with octamer transcription factor-1 and acts as a transcriptional repressor.
Kakizawa T; Miyamoto T; Ichikawa K; Takeda T; Suzuki S; Mori J; Kumagai M; Yamashita K; Hashizume K
J Biol Chem; 2001 Mar; 276(13):9720-5. PubMed ID: 11134019
[TBL] [Abstract][Full Text] [Related]
23. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins.
Strubin M; Newell JW; Matthias P
Cell; 1995 Feb; 80(3):497-506. PubMed ID: 7859290
[TBL] [Abstract][Full Text] [Related]
24. NCoA-1/SRC-1 is an essential coactivator of STAT5 that binds to the FDL motif in the alpha-helical region of the STAT5 transactivation domain.
Litterst CM; Kliem S; Marilley D; Pfitzner E
J Biol Chem; 2003 Nov; 278(46):45340-51. PubMed ID: 12954634
[TBL] [Abstract][Full Text] [Related]
25. Transcriptional inhibition by Stat5. Differential activities at growth-related versus differentiation-specific promoters.
Luo G; Yu-Lee L
J Biol Chem; 1997 Oct; 272(43):26841-9. PubMed ID: 9341115
[TBL] [Abstract][Full Text] [Related]
26. POU domain factors in neural development.
Schonemann MD; Ryan AK; Erkman L; McEvilly RJ; Bermingham J; Rosenfeld MG
Adv Exp Med Biol; 1998; 449():39-53. PubMed ID: 10026784
[TBL] [Abstract][Full Text] [Related]
27. Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1.
Schubart DB; Sauter P; Massa S; Friedl EM; Schwarzenbach H; Matthias P
Nucleic Acids Res; 1996 May; 24(10):1913-20. PubMed ID: 8657574
[TBL] [Abstract][Full Text] [Related]
28. The significance of tetramerization in promoter recruitment by Stat5.
John S; Vinkemeier U; Soldaini E; Darnell JE; Leonard WJ
Mol Cell Biol; 1999 Mar; 19(3):1910-8. PubMed ID: 10022878
[TBL] [Abstract][Full Text] [Related]
29. Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex: specific recognition of a protein-DNA interface.
Chasman D; Cepek K; Sharp PA; Pabo CO
Genes Dev; 1999 Oct; 13(20):2650-7. PubMed ID: 10541551
[TBL] [Abstract][Full Text] [Related]
30. Lymphoid-specific transcription mediated by the conserved octamer site: who is doing what?
Matthias P
Semin Immunol; 1998 Apr; 10(2):155-63. PubMed ID: 9618761
[TBL] [Abstract][Full Text] [Related]
31. Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors.
Groner B; Fritsche M; Stöcklin E; Berchtold S; Merkle C; Moriggl R; Pfitzner E
Growth Horm IGF Res; 2000 Apr; 10 Suppl B():S15-20. PubMed ID: 10984248
[TBL] [Abstract][Full Text] [Related]
32. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5.
Matsumura I; Ishikawa J; Nakajima K; Oritani K; Tomiyama Y; Miyagawa J; Kato T; Miyazaki H; Matsuzawa Y; Kanakura Y
Mol Cell Biol; 1997 May; 17(5):2933-43. PubMed ID: 9111365
[TBL] [Abstract][Full Text] [Related]
33. The coactivator of transcription CREB-binding protein interacts preferentially with the glycosylated form of Stat5.
Gewinner C; Hart G; Zachara N; Cole R; Beisenherz-Huss C; Groner B
J Biol Chem; 2004 Jan; 279(5):3563-72. PubMed ID: 14597631
[TBL] [Abstract][Full Text] [Related]
34. Advanced glycation end product-induced proliferation in NRK-49F cells is dependent on the JAK2/STAT5 pathway and cyclin D1.
Guh JY; Huang JS; Chen HC; Hung WC; Lai YH; Chuang LY
Am J Kidney Dis; 2001 Nov; 38(5):1096-104. PubMed ID: 11684565
[TBL] [Abstract][Full Text] [Related]
35. Identification of a distal STAT5-binding DNA region that may mediate growth hormone regulation of insulin-like growth factor-I gene expression.
Wang Y; Jiang H
J Biol Chem; 2005 Mar; 280(12):10955-63. PubMed ID: 15677453
[TBL] [Abstract][Full Text] [Related]
36. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone.
Silva CM; Lu H; Day RN
Mol Endocrinol; 1996 May; 10(5):508-18. PubMed ID: 8732682
[TBL] [Abstract][Full Text] [Related]
37. Interactions of the Oct-1 POU subdomains with specific DNA sequences and with the HSV alpha-trans-activator protein.
Kristie TM; Sharp PA
Genes Dev; 1990 Dec; 4(12B):2383-96. PubMed ID: 1980658
[TBL] [Abstract][Full Text] [Related]
38. The Oct-1 POU domain mediates interactions between Oct-1 and other POU proteins.
Verrijzer CP; van Oosterhout JA; van der Vliet PC
Mol Cell Biol; 1992 Feb; 12(2):542-51. PubMed ID: 1346336
[TBL] [Abstract][Full Text] [Related]
39. Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA.
Sauter P; Matthias P
Mol Cell Biol; 1998 Dec; 18(12):7397-409. PubMed ID: 9819426
[TBL] [Abstract][Full Text] [Related]
40. Deletion of the carboxyl-terminal transactivation domain of MGF-Stat5 results in sustained DNA binding and a dominant negative phenotype.
Moriggl R; Gouilleux-Gruart V; Jähne R; Berchtold S; Gartmann C; Liu X; Hennighausen L; Sotiropoulos A; Groner B; Gouilleux F
Mol Cell Biol; 1996 Oct; 16(10):5691-700. PubMed ID: 8816482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
